Omega Therapeutics stock is now associated with a post-effective-date liquidation under a plan that became effective on August 8, 2025. The case remains active for claims administration, with a November 2, 2026 deadline providing the clearest dated checkpoint for the company.
Liquidation plan took effect
According to ElevenFlo, the plan was confirmed on July 31, 2025, and became effective eight days later on August 8, 2025. That sequence marks the shift from court confirmation to post-effective-date administration.
The bankruptcy petition was filed on February 10, 2025, under case number 25-10211 in the United States Bankruptcy Court for the District of Delaware, according to ElevenFlo. The petition listed assets of USD 100 million to…